Stock screener

TXG

Conviction 100IndustrialsScan · Mon, Aug 10, 2026
TXG$58.62+12.67%
ResistanceSupportVol 14Insider sell
63 bars
4
2
3
Vol MA14 3.75M
May 11May 28Jun 16Jul 6Jul 23Aug 10
10x Genomics, Inc.LABORATORY ANALYTICAL INSTRUMENTSwww.10xgenomics.com
Price58.62
Change+12.67%
Gap-0.70%
Rel volume5.05×
Avg volume3.66M
Avg $ vol180.37M
SMA 2047.31
SMA 5039.55
SMA 20024.48
Price vs 50+48.22%
Price vs 200+139.47%
MA stackbullish
50/200 cross
Supertrendup · 43.90
RSI (14)75
MACD hist0.37
MACD crossbull · 0d
Stoch %K / %D92 / 78
ADX (14)40
+DI / −DI42 / 12
RSI divergenceBearish
MACD divergenceBearish
ATR %+6.00%
ADR %6.84%
52w high58.62
52w low11.34
From 52w high+0.00%
Above 52w low+416.93%
New 52w highYes
SqueezeOff
Bollinger width27.07%
%B1.38
Donchian pos93.34%
Donchian high59.81
Donchian low41.93
AVWAP (52w high)56.47
vs AVWAP high+3.82%
AVWAP (52w low)25.36
vs AVWAP low+131.11%
OBV trendFlat
Chaikin MF (20)0.35
Today vs 20d5.05×
Avg vol (14d)3.75M
Avg vol (20d)3.66M
Avg $ vol (20d)180.37M
Market cap7.49B
RS 3m (vs SPY)+126.37%
RS 6m (vs SPY)+179.84%
RS line new highYes
Trend template8/8
Technical rank97.7
1 week+24.70%
1 month+37.19%
3 months+171.39%
6 months+214.99%
1 year+357.97%
YTD+252.71%
P/E-171.90
P/B9.07
P/S11.64
P/FCF57.53
EPS-0.3500
Div yield
ROE-5.27%
ROA-4.23%
Debt/Eq0.00
Current5.69
EV/EBITDA-288.11
Gross margin69.05%
Net margin-6.77%
Rev growth5.25%
EPS growth76.16%
Price target46.50
Target upside-20.68%
Analyst ratingHold
Institutional119.55%
Ent. value7.14B
Revenue151.04M
Net income-17.93M
Gross profit112.5M
Free cash flow130.12M
IndustryLABORATORY ANALYTICAL INSTRUMENTS
ExchangeNasdaq
Shares out116.88M
Employees1.18K
ListedThu, Sep 12, 2019
Free float113.98M
Float %96.9%
Short interest16.25M
Days to cover5.3d
Short volume67.1%
Squeeze score87 / 100
Next earnings
EPS forecast
Last EPS vs est−$0.14 vs −$0.23
Last surprise+39.1% beat
Setup gradeA+
Conviction100 / 100
Pattern quality
Tech rank97.7 / 100
Group rank68 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance49.92
Support33.21
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TXG

All disclosures →
No recent disclosed trades by Congress in TXG. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TXG · 3 buys · 6 sells

InsiderSideShares
Saxonov Serge
Chief Executive Officer · Class A Common Stock · 2026-06-22
Sell9.82K
Saxonov Serge
Chief Executive Officer · Class A Common Stock · 2026-06-22
Sell1.66K
Saxonov Serge
Chief Executive Officer · Class A Common Stock · 2026-06-22
Sell8.53K
Saxonov Serge
Chief Executive Officer · Class A Common Stock · 2026-06-22
Sell9.99K
SULIMAN SHEHNAAZ
Director · Class A Common Stock · 2026-06-16
Sell5.36K
SULIMAN SHEHNAAZ
Director · Class A Common Stock · 2026-06-16
Sell364
Kosaraju Sridhar
Director · Class A Common Stock · 2026-06-04
Grant8.83K
MATEO ALAN
Director · Class A Common Stock · 2026-06-04
Grant8.83K
Kosaraju Sridhar
Director · Class A Common Stock · 2026-06-04
Other
Teichmann Sarah A.
Director · Class A Common Stock · 2026-06-04
Grant8.83K

SEC filings

EDGAR filings in TXG · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.